On November 28, Guolonghui reported that Tianjin Ringpu Bio-Technology (300119.SZ) announced that Tianjin Ringpu Bio-Technology Co., Ltd. and its subsidiaries Ringpu (Tianjin) Biopharmaceutical Co., Ltd., Shanxi Ruixiang Biopharmaceutical Co., Ltd., and Hubei Longxiang Pharmaceutical Biotechnology Co., Ltd. recently obtained the "New Veterinary Drug Registration Certificate" issued by the Ministry of Agriculture and Rural Affairs in accordance with the regulations of the Veterinary Drug Administration Regulations and the Veterinary Drug Registration Measures. The related new veterinary drug names are hydrochloride voriconazole dihydrate and hydrochloride voriconazole dihydrate soluble powder.
In the context of the global campaign to reduce antibiotics resistance, the hydrochloride voriconazole dihydrate soluble powder, compared with the truncation cephalosporin antibiotic tilmicosin, reduces the clinical dosage by more than 30% for the treatment of poultry Mycoplasma, significantly reducing medication costs; Furthermore, this product is rapidly metabolized in the target animal chicken, with a withdrawal period of only 2 days, which helps to control animal food safety. The successful research and approval of this product provide a safer, compliant, economical, efficient, and low-residue choice for the prevention and control of Mycoplasma in poultry farming.
